BENEFIT OF INFLIXIMAB RE-INTRODUCTION AFTER SUCCESSIVE FAILURE OF INFLIXIMAB AND ADALIMUMAB IN INFLAMMATORY BOWEL DISEASES

Charlotte Gagniere  1     Laurent Beaugerie  1     Benjamin Pariente  2     Philippe Seksik  1     Aurelien Amiot  3     Vered Abitbol  4     Matthieu Allez  2     Jacques Cosnes  1     Harry Sokol  1    
1 Saint Antoine Hospital
2 Saint Louis Hospital
3 Mondor Hospital
4 Cochin Hospital

Session
IBD I

Conference
UEG Week 2013

Citation
United European Gastroenterology Journal; 2013: 1 (Supplement 1) A217


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing